Nabi Biopharmaceuticals · Rockville, MD United States ·(NASDAQ (GM): NABI)
Company Description
Phone: 301-770-3099
Fax: 301-770-3097
Toll Free: 800-685-5579
View Nabi Biopharmaceuticals Locations On A US Map
This link will open in a new window
Nabi Biopharmaceuticals nabs human antibodies to make pharmaceutical therapies. The biotechnology company makes vaccine products for diseases in a number of areas, including infectious diseases and nicotine addiction. Its vaccine for nicotine addition, NicVAX, works by stimulating antibodies that reduce cravings. It had been developing StaphVax, an investigational vaccine designed to fight certain hospital-acquired infections, until it failed certain trials. The company modified the drug and renamed it PentaStaph. Nabi had marketed one product, hepatitis B vaccine Nabi-HB; but it sold Nabi-HB along with some other assets in 2007 in order to focus on its other development programs. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Nabi Biopharmaceuticals Financials
| Company Type | Public - NASDAQ (GM): NABI Headquarters |
| Fiscal Year-End | December |
| 2008 Sales (mil.) | $0.0 |
| 2008 Employees | 40 |
Nabi Biopharmaceuticals Executives
15 executives listed for Nabi Biopharmaceuticals's Rockville, MD location.
| Title | Name & Bio | Contact |
| Chairman | Geoffrey Cox | Network |
| President, CEO, Acting CFO, and Director | Raafat Fahim | Network |
| SVP Strategic Planning and Business Operations | Matthew Kalnik | Network |
Competition
Competitive Landscape for Nabi Biopharmaceuticals
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top Nabi Biopharmaceuticals Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
